Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists.
Cristina RebordosaEstel PlanaAnnalisa RubinoJaume AguadoDavid MartinezAlejhandra LeiSami DaoudNuria Saigi-MorguiSusanna Perez-GutthannElena Rivero-FerrerPublished in: International journal of chronic obstructive pulmonary disease (2022)
Risks of AMI, stroke, and MACE in current users of aclidinium, aclidinium/formoterol, tiotropium, other LAMA, LAMA/LABA, or LABA/ICS were similar to the risks among current users of LABA.